Skip to main content
. Author manuscript; available in PMC: 2022 Nov 4.
Published in final edited form as: Ann Surg. 2019 Sep;270(3):400–413. doi: 10.1097/SLA.0000000000003468

FIGURE 2.

FIGURE 2.

CA 19–9 levels trend during treatment course demonstrating the biochemical response. CA 19–9 level decline greater than 50% after neoadjuvant chemotherapy (NAC) compared with baseline levels was 70% (FLX) and 84% (GNP).